SCHEMBL2975670

SCHEMBL2975670

C1=C(OCc2ccccc2)CCN1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.47
HTR2C P28335 2/20 0.41
HTR2B P41595 1/20 0.41
SLC6A2 P23975 3/20 0.41
SLC6A3 Q01959 3/20 0.41
MAOB P27338 3/20 0.41
HTR1A P08908 2/20 0.41
SLC6A4 P31645 2/20 0.41
CYP2C19 P33261 2/20 0.40
TSHR P16473 1/20 0.40
HTR2A P28223 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
HIF1A Q16665 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
MAPT P10636 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MAOA P21397 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14305067 0.75 HTT (0.49) HTTHTR2CHTR2BSLC6A2SLC6A3
SCHEMBL13068859 0.73 HTT (0.71) HTTHTR2CHTR2BMAOBL3MBTL1
SCHEMBL10693246 0.70 HTT (0.51) HTTHTR2CHTR2BSLC6A2SLC6A3
SCHEMBL6469379 0.69 TSHR (0.52) HTTSLC6A2SLC6A3MAOBHTR1A
SCHEMBL6327555 0.68 CYP3A4 (0.47) HTTHTR2CHTR2BSLC6A2SLC6A3
SCHEMBL7993157 0.68 HTT (0.49) HTTSLC6A2SLC6A3MAOBHTR1A
SCHEMBL27923718 0.67 HTT (0.44) HTTHTR2CSLC6A2SLC6A3MAOB
SCHEMBL9609521 0.67 HTT (0.56) HTTSLC6A2SLC6A3MAOBCYP2C19
SCHEMBL6433409 0.67 HTT (0.44) HTTHTR2CHTR2BSLC6A2SLC6A3
SCHEMBL3660167 0.66 TSHR (0.48) SLC6A2SLC6A3MAOBHTR1ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1950198-B1 PROCESS FOR PRODUCTION OF BENZYLOXYPYRROLIDINE DERIVATIVE, AND PROCESS FOR PRODUCTION OF HYDROCHLORIDE SALT POWDER OF OPTICALLY ACTIVE BENZYLOXYPYRROLIDINE DERIVATIVE TORAY FINECHEMICALS CO LTD (JP) 2014-08-06 EP disclosed
US-7772406-B2 Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative TORAY FINE CHEMICALS CO., LTD. (JP) 2010-08-10 US disclosed
US-20090093643-A1 Process for Production of Benzyloxypyrrolidine Derivative, and Process for Production of Hydrochloride Salt Powder of Optically Active Benzyloxypyrrolidine Derivative TORAY FINE CHEMICALS CO., LTD. (JP) 2009-04-09 US disclosed
EP-1950198-A1 PROCESS FOR PRODUCTION OF BENZYLOXYPYRROLIDINE DERIVATIVE, AND PROCESS FOR PRODUCTION OF HYDROCHLORIDE SALT POWDER OF OPTICALLY ACTIVE BENZYLOXYPYRROLIDINE DERIVATIVE Toray Fine Chemicals Co., Ltd. (JP) 2008-07-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093643-A1 Process for Production of Benzyloxypyrrolidine Derivative, and Process for Production of Hydrochloride Salt Powder of Optically Active Benzyloxypyrrolidine Derivative HPD, PAH, DHPS HTT 1814/4885HTR2C 1924/4885HTR2B 1896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.